Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Asia-Pacific Journal of Clinical Oncology|September 3, 2020
Real-world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian CenterKennedy Yao Yi Ng, Lawrence Wen Jun Wong, Andrea Jing Shi Ang, et al.
Immunotherapy Advances|August 28, 2023
Lytic efficiency of immunosuppressive drug-resistant armoured T cells against circulating HBV-related HCC in whole bloodMeiyin Lin, Sebastian Chakrit Bhakdi, Damien Tan, et al.
Liver Cancer|March 6, 2023
First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Patient-Level Network Meta-AnalysisKhi Yung Fong, Joseph Jonathan Zhao, Rehena Sultana, et al.
Digestive Diseases and Sciences|February 25, 2026
Using the EVendo Score to Predict Varices and Varices Needing Treatment in Hepatocellular Carcinoma Patients Planned for Atezolizumab-BevacizumabSuat Ying Lee, Chiew Woon Lim, Sejin Kim, et al.
Cancer Chemotherapy and Pharmacology|December 3, 2017
Metabolomic prediction of treatment outcome in pancreatic ductal adenocarcinoma patients receiving gemcitabineLee Cheng Phua, Shixu Goh, David Wai Meng Tai, et al.
Surgery|December 11, 2025
Neoadjuvant therapy versus upfront surgery for resectable pancreatic cancer: Updated systematic review, individual-patient-data meta-analysis and trial sequential analysis of randomized controlled trialsHwee Leong Tan, Yun Zhao, Darren Weiquan Chua, et al.
World Journal of Gastrointestinal Oncology|March 28, 2017
Gastric peritoneal carcinomatosis - a retrospective reviewHwee Leong Tan, Claramae Shulyn Chia, Grace Hwei Ching Tan, et al.
Asia-Pacific Journal of Clinical Oncology|June 20, 2018
Metastatic gastric cancer: Does the site of metastasis make a difference?Hwee Leong Tan, Claramae Shulyn Chia, Grace Hwei Ching Tan, et al.
Asia-Pacific Journal of Clinical Oncology|August 11, 2022
Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?Kennedy Yao Yi Ng, Lawrence Wen Jun Wong, Andrea Jing Shi Ang, et al.
Liver Cancer|February 28, 2022
Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular CarcinomaKennedy Yao Yi Ng, Sze Huey Tan, Jack Jie En Tan, et al.
Pageof 4